BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12614213)

  • 1. Prospective evaluation of cell kinetics, yields and donor experiences during a single large-volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells.
    Bolan CD; Carter CS; Wesley RA; Yau YY; Barrett AJ; Childs RW; Read EJ; Leitman SF
    Br J Haematol; 2003 Mar; 120(5):801-7. PubMed ID: 12614213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.
    Vasu S; Leitman SF; Tisdale JF; Hsieh MM; Childs RW; Barrett AJ; Fowler DH; Bishop MR; Kang EM; Malech HL; Dunbar CE; Khuu HM; Wesley R; Yau YY; Bolan CD
    Blood; 2008 Sep; 112(5):2092-100. PubMed ID: 18523146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection of two peripheral blood stem cell concentrates from healthy donors.
    Stroncek DF; Clay ME; Jaszcz W; Lennon S; Smith J; McCullough J
    Transfus Med; 1999 Mar; 9(1):37-50. PubMed ID: 10216904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency.
    Tichelli A; Passweg J; Hoffmann T; Gregor M; Kühne T; Favre G; Wodnar-Filipowicz A; Gratwohl A
    Br J Haematol; 1999 Jul; 106(1):152-8. PubMed ID: 10444178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
    Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
    Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?
    Lysák D; Kořístek Z; Gašová Z; Skoumalová I; Jindra P
    J Clin Apher; 2011; 26(1):9-16. PubMed ID: 21312254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
    Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the CD34
    Guo ZP; Wang T; Xu LP; Zhang XH; Wang Y; Huang XJ; Chang YJ
    Transfus Apher Sci; 2016 Dec; 55(3):311-317. PubMed ID: 27665155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of monocyte count: a good predictor for timing of peripheral blood stem cell collection.
    Yang SM; Chen H; Chen YH; Zhu HH; Zhao T; Liu KY
    J Clin Apher; 2012; 27(4):193-9. PubMed ID: 22532123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
    Hsu JW; Shaw BE; Kim S; Logan BR; Sees JA; Confer DL; Pulsipher MA; Shah N; Switzer GE; Abidi MH; Ahmed IA; Anderlini PN; Bredeson C; Chhabra S; Dandoy CE; Diaz MA; Farhadfar N; Ganguly S; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Olsson RF; Savani BN; Schears R; Seo S; Solh M; Spitzer T; Steinberg A; Sugrue M; Warkentin P; Wingard JR
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1210-1217. PubMed ID: 32088366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis.
    Rowley SD; Yu J; Gooley T; Heimfeld S; Holmberg L; Maloney D; Bensinger WI
    Bone Marrow Transplant; 2001 Oct; 28(7):649-56. PubMed ID: 11704787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.